Literature DB >> 17512981

Anticonvulsant effects of damage to structures involved in seizure induction in rats exposed to soman.

Trond Myhrer1, Siri Enger, Pål Aas.   

Abstract

In nerve agent research, it is assumed that the regions from which seizure activity is triggered may offer clues for the designing of effective anticonvulsive therapy. In the present study, selective brain lesions were made to identify critical cholinergic pathways and seizure controlling areas involved in the induction of epileptiform activity in rats challenged with soman. The results showed that rats with bilateral aspiration lesion of the seizure controlling substrate, area tempestas (AT) in the piriform cortex, displayed marked anticonvulsant effects, whereas such effects were not seen when substantia nigra was destroyed. Aspiration lesion of the medial septal area (MS) including the vertical limb of the diagonal band nucleus (DBN) caused increased latency to the onset of convulsions, whereas damage to the nucleus basalis magnocellularis (NBM), nucleus accumbens, or both MS and NBM did not cause anticonvulsant effects. Saporin lesion of MS, DBN (horizontal limb), or MS+DBN had no anticonvulsant effects, suggesting that aspiration lesion of MS disrupted pathways beyond cholinergic ones. Severe aphagia/adipsia and reduced body weight occurred in rats with lesions in the septal area. In separate sham operated rats, a strong positive correlation was found between body weight and latency to onset of convulsions in response to soman. Thus, weight loss and a relatively high dose of soman (1.6 x LD(50)) in this context may have masked potential anticonvulsant effects among some lesioned animals. It is inferred that MS and AT/piriform cortex occur as prime target areas for induction of seizures by soman.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512981     DOI: 10.1016/j.neuro.2007.03.010

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  5 in total

1.  The M1 Muscarinic Receptor Antagonist VU0255035 Delays the Development of Status Epilepticus after Organophosphate Exposure and Prevents Hyperexcitability in the Basolateral Amygdala.

Authors:  Steven L Miller; Vassiliki Aroniadou-Anderjaska; Volodymyr I Pidoplichko; Taiza H Figueiredo; James P Apland; Jishnu K S Krishnan; Maria F M Braga
Journal:  J Pharmacol Exp Ther       Date:  2016-10-31       Impact factor: 4.030

2.  Neuroprotection From Organophosphate-Induced Damage by Novel Phenoxyalkyl Pyridinium Oximes in Rat Brain.

Authors:  Ronald B Pringle; Edward C Meek; Howard W Chambers; Janice E Chambers
Journal:  Toxicol Sci       Date:  2018-12-01       Impact factor: 4.849

3.  Transcriptional responses of the nerve agent-sensitive brain regions amygdala, hippocampus, piriform cortex, septum, and thalamus following exposure to the organophosphonate anticholinesterase sarin.

Authors:  Kimberly D Spradling; Lucille A Lumley; Christopher L Robison; James L Meyerhoff; James F Dillman
Journal:  J Neuroinflammation       Date:  2011-07-21       Impact factor: 8.322

4.  Transcriptional analysis of rat piriform cortex following exposure to the organophosphonate anticholinesterase sarin and induction of seizures.

Authors:  Kimberly D Spradling; Lucille A Lumley; Christopher L Robison; James L Meyerhoff; James F Dillman
Journal:  J Neuroinflammation       Date:  2011-07-21       Impact factor: 8.322

5.  Acute Health Effects and Outcome Following Sarin Gas Attacks in Khan Shaykhun, Syria.

Authors:  Osama I Alsaleh; Abdallah M Elsafti Elsaeidy; Saad Saeed; Abdulrahman Alhallak; Mazen A Altelawi; Gerlant Van Berlaer; Ives Hubloue
Journal:  Cureus       Date:  2022-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.